COVID-19 Vaccine Grants

As a leader in the development of vaccines, Pfizer is proud to support independent efforts in areas of research, education and quality improvement with a primary goal of optimizing the prevention of COVID-19 . Given the urgency and complexity of efforts required to respond to the global pandemic, we are launching our COVID-19 vaccine grant program in phases.

COVID-19 VACCINE GENERAL RESEARCH

Learn more about General Research grants

The following areas of research will be considered:

• Studies evaluating COVID-19 burden, long-term or secondary consequences of the disease, healthcare resource utilization, direct and indirect costs and impact on QoL, with particular focus on pediatric, adolescents and special populations.
• Studies measuring the impact of efforts to overcome vaccine hesitancy and enhance vaccine uptake, especially in pediatric, adolescents, minorities and underserved populations.
• Epidemiology studies on SARS-CoV-2 variant evolution, specifically impact on transmission and clinical course of disease.

Submit a new application or view an existing application through our Grant System

COVID-19 VACCINE INDEPENDENT MEDICAL EDUCATION

Coming soon!

Optimize the prevention of COVID-19 by:

• Increase awareness of the risk of COVID-19 for all ages and racial and ethnic groups.
• Increase the understanding, and familiarity with, the proper storage, handling and administration of Pfizer’s vaccine.

COVID-19 VACCINE POPULATION HEALTH

Optimize the prevention of COVID-19 by increasing the understanding and familiarity with COVID-19 and Pfizer’s COVID-19 vaccine among the general population.